Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Large scale data storage system with fault tolerance
Support for a parameterized query/view in complex event processing
Systems and methods for online search recirculation and query categorization
Digital media content distribution
Apparatus and method for transmitting and receiving data
Haloalky -substituted amides as insecticides and acaricides
Mask blank, transfer mask, and film denseness evaluation method
  Randomly Featured Patents
Light source unit
Replaceable cutting bit holder assembly
Automatic article clamping device
System and method for group advertisement optimization
Disposable bed covering
Method for synthesizing extremely high-temperature melting materials
System and method for generation and authentication of a signed document using voice analysis
Multi-fuel bib
Exhaust stack support arrangement
Fabrication method for semiconductor devices